Kevan Herold MD

Professor of Immunobiology and of Medicine (Endocrinology); Deputy Director for Translational Science, YCCI; Director, Yale Diabetes Center


Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Immunology

Stem Cell Center, Yale: Transcriptional Regulation of Stem and Progenitor Cells

Immunobiology: HTI | Herold Lab

Internal Medicine: Endocrinology: Diabetes Center | Diabetes Research Center

NIH T32 Program

Biography

My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms. My focus has largely been in the field of autoimmune Type 1 diabetes. The work encompasses basic laboratory work understanding the regulation of autoreactive T cells to clinical trials that involve novel therapeutics. As part of these studies I have also been very interested in analysis of beta cell function in Type 1 diabetes.


Education

  • BS, Pennsylvania State University , 1977
  • M.D., Jefferson Medical College , 1979

Selected Publication

  • Ablamunits V, Henegariu O, Hansen JB, Opare-Addo L, Preston-Hurlburt P, Santamaria P, Mandrup-Poulsen T, and Herold KC. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and IL-1 blockade: evidence of improved immune regulation (in press) Diabetes.